These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7853186)

  • 21. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
    Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
    J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WY-50295 tromethamine: a 5-lipoxygenase inhibitor without activity in human whole blood.
    Carlson R; Kreft A; Hartman D; Tomchek L; Lock Y; Weichman B; Glaser K
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):31-41. PubMed ID: 10319915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea.
    Adams JL; Garigipati RS; Sorenson M; Schmidt SJ; Brian WR; Newton JF; Tyrrell KA; Garver E; Yodis LA; Chabot-Fletcher M; Tzimas M; Webb EF; Breton JJ; Griswold DE
    J Med Chem; 1996 Dec; 39(26):5035-46. PubMed ID: 8978834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
    Shirumalla RK; Sharma P; Dastidar SG; Paliwal JK; Kakar S; Varshney B; Singh Saini G; Sattigeri V; Salman M; Ray A
    Inflamm Res; 2008 Mar; 57(3):135-43. PubMed ID: 18369577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
    Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
    Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay.
    Bouska JJ; Bell RL; Goodfellow CL; Stewart AO; Brooks CD; Carter GW
    Drug Metab Dispos; 1997 Sep; 25(9):1032-8. PubMed ID: 9311617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a selective 5-lipoxygenase inhibitor, zileuton, on tissue damage in acute colonic inflammation in rats.
    Zarif A; Eiznhamer D; Callaghan C; Doria MI; Broutman L; Keshavarzian A
    Inflammation; 1996 Jun; 20(3):217-27. PubMed ID: 8796377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
    Nickerson-Nutter CL; Medvedeff ED
    Arthritis Rheum; 1996 Mar; 39(3):515-21. PubMed ID: 8607901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
    Wong SL; Drajesk J; Chang M; Lanni C; Witt G; Hansen R; Awni WM
    Clin Pharmacol Ther; 1998 Mar; 63(3):324-31. PubMed ID: 9542476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical and clinical activity of zileuton and A-78773.
    Bell RL; Lanni C; Malo PE; Brooks DW; Stewart AO; Hansen R; Rubin P; Carter GW
    Ann N Y Acad Sci; 1993 Nov; 696():205-15. PubMed ID: 8109828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
    Rao TS; Yu SS; Djuric SW; Isakson PC
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
    Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
    Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
    Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
    Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
    Knapp HR
    N Engl J Med; 1990 Dec; 323(25):1745-8. PubMed ID: 1701029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
    Mangino MJ; Murphy MK; Anderson CB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):75-81. PubMed ID: 8169854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.